Comparison

Brivanib Alaninate European Partner

Item no. TMO-T2576-10mg
Manufacturer TargetMol
CASRN 649735-63-7
Amount 10mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles Cc1cc2c(ccc(c2F)Oc2c3c(C)c(cn3ncn2)OC[C@@H](C)OC(=O)[C@H](C)N)[nH]1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Brivanib alaninate, BMS-582664; BMS 582664; BMS582664, VEGFR inhibitor;FGFR inhibitor, BMS-582664 , Brivanib Alaninate
Similar products 649735-63-7
Available
Short Description
Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
Shipping
cool pack
Storage
-20°
Target names or alias
BMS-582664 , Brivanib Alaninate
Molecular Weight
441, 46
Pathway
Autophagy|||Angiogenesis|||Tyrosine Kinase/Adaptors
Target
VEGFR|||FGFR|||Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close